Gut microbes and adverse food reactions: Focus on gluten related disorders

被引:29
|
作者
Galipeau, Heather J. [1 ]
Verdu, Elena F. [1 ]
机构
[1] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada
关键词
celiac disease; gluten related disorders; immune homeostasis; microbiota; oral tolerance; CELIAC-DISEASE; GERM-FREE; T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; DUODENAL MICROBIOTA; NATURAL-HISTORY; UNITED-STATES; FREE DIET;
D O I
10.4161/19490976.2014.969635
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Immediately following birth, the gastrointestinal tract is colonized with a complex community of bacteria, which helps shape the immune system. Under conditions of health, the immune system is able to differentiate between innocuous antigens, including food protein and commensals, and harmful antigens such as pathogens. However, patients with celiac disease (CD) develop an intolerance to gluten proteins which results in a pro-inflammatory T-cell mediated immune response with production of anti-gluten and anti-tissue transglutaminase antibodies. This adaptive immune response, in conjunction with activation of innate inflammatory cells, lead to destruction of the small intestinal mucosa. Overall 30% of the global population has genetic risk to develop CD. However, only a small proportion develop CD, suggesting that additional environmental factors must play a role in disease pathogenesis. Alterations in small intestinal microbial composition have recently been associated with active CD, indicating a possible role for the microbiota in CD. However, studies demonstrating causality are lacking. This review will highlight the recent data on the potential role of the microbiota in CD pathogenesis, the potential mechanisms, and discuss future research directions.
引用
收藏
页码:594 / 605
页数:12
相关论文
共 50 条
  • [41] CAN GUT MICROBES PLAY A ROLE IN MENTAL DISORDERS AND THEIR TREATMENT?
    Latalova, Klara
    Hajda, Miroslav
    Prasko, Jan
    PSYCHIATRIA DANUBINA, 2017, 29 (01) : 28 - 30
  • [42] Human gut microbes are susceptible to antimicrobial food additives in vitro
    Lucia Hrncirova
    Tomas Hudcovic
    Eliska Sukova
    Vladimira Machova
    Eva Trckova
    Jan Krejsek
    Tomas Hrncir
    Folia Microbiologica, 2019, 64 : 497 - 508
  • [43] Gut microbes participate in food preference alterations during obesity
    d'Oplinter, Alice de Wouters
    Rastelli, Marialetizia
    Van Hul, Matthias
    Delzenne, Nathalie M.
    Cani, Patrice D.
    Everard, Amandine
    GUT MICROBES, 2021, 13 (01)
  • [44] Human gut microbes are susceptible to antimicrobial food additives in vitro
    Hrncirova, Lucia
    Hudcovic, Tomas
    Sukova, Eliska
    Machova, Vladimira
    Trckova, Eva
    Krejsek, Jan
    Hrncir, Tomas
    FOLIA MICROBIOLOGICA, 2019, 64 (04) : 497 - 508
  • [45] Gluten-related disorders and demyelinating diseases
    Hernandez-Lahoz, Carlos
    Rodrigo, Luis
    MEDICINA CLINICA, 2013, 140 (07): : 314 - 319
  • [46] Recent Advances in Gluten-Related Disorders
    Smolinska, Sylwia
    Jurkiewicz, Krzysztof
    Majsiak, Emilia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [47] Clinical and diagnostic aspects of gluten related disorders
    Francesco Tovoli
    Chiara Masi
    Elena Guidetti
    Giulia Negrini
    Paola Paterini
    Luigi Bolondi
    World Journal of Clinical Cases, 2015, (03) : 275 - 284
  • [48] Clinical and diagnostic aspects of gluten related disorders
    Tovoli, Francesco
    Masi, Chiara
    Guidetti, Elena
    Negrini, Giulia
    Paterini, Paola
    Bolondi, Luigi
    WORLD JOURNAL OF CLINICAL CASES, 2015, 3 (03) : 275 - 284
  • [49] Bacterial microcompartments in food-related microbes
    Zeng, Zhe
    Dank, Alexander
    Smid, Eddy J.
    Notebaart, Richard A.
    Abee, Tjakko
    CURRENT OPINION IN FOOD SCIENCE, 2022, 43 : 128 - 135
  • [50] Uncovering the skin reactions: Retrospectively analyzing the adverse drug reactions related to skin & subcutaneous tissues disorders
    Syed, Jehath M.
    Ramesh, Madhan
    Chalasani, Sri Harsha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 499 - 499